Document is current

Any future updates will be listed below

144 Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.0144

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark